Home / Science / Accidental Lab Discovery Cured Cancer
Accidental Lab Discovery Cured Cancer
3 Jun
Summary
- Platinum electrodes unexpectedly created a cancer-fighting compound.
- Bacteria's division failure led to potential tumor growth inhibition.
- Cisplatin, found in 1965, gained FDA approval in 1978.
In 1965, a scientific experiment at Michigan State University unexpectedly yielded a breakthrough in cancer treatment. Biophysicist Barnett Rosenberg, studying electric fields' effect on E. coli, observed that platinum electrodes caused bacteria to grow abnormally long and narrow instead of dividing.
This serendipitous event revealed that a dissolved platinum compound could halt cellular division. Rosenberg hypothesized that this substance might inhibit the rapid division characteristic of cancer cells, initiating a long research journey.
Extensive testing on lab rats with tumors demonstrated the compound's efficacy in reducing cancerous cell growth and tumor size. This validated the initial observation and paved the way for medical applications.
After rigorous clinical trials to assess safety and efficacy, cisplatin received FDA approval for medical use in 1978, a decade after its initial discovery.
Today, cisplatin is a crucial weapon against various cancers, including testicular, ovarian, and bladder cancers. Its discovery also spurred the development of other platinum-based drugs, saving countless lives globally.
